A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
How a hands-off AP approach fueled by data insights can drive bottom-line results for healthcare organizations.
The PINC AI™ Applied Sciences team and their partners continue their work to develop long-lasting solutions to our nation’s health equity crisis.
Premier recommends ways for FDA to incorporate emerging technologies into drug development and provide clarity for manufacturers.
Premier urges the DEA to ensure reductions in opioid manufacturing quotas do not exacerbate recent drug shortages.
PINC AI™ Applied Sciences is committed to advancing health equity through real-world, data-driven research and solutions co-designed with health systems and life sciences partners.
Life sciences companies need to invest in RWD/RWE as payers, regulatory bodies, and health systems demand proof that a medical solution delivers real value.
Tufts Medicine and Premier are undertaking a 10-year strategic partnership to expand and extend their shared supply chain goals and capabilities.
Builds on efforts to create healthier pharmaceutical markets that ensure continuous access and prevent shortages that can compromise patient care.
PM360 |
Data clearly matters in pharma. For the fourth year in a row AI and Big Data ranked as the most impactful technologies in the industry.
Forbes |
From improving patient outcomes and easing clinicians’ workloads to advancing clinical trials and predicting supply shortages, AI is supporting better, smarter, faster healthcare.
Premier responds to CMS' final rule to compensate hospitals for past underpayments for 340B drugs.
Examine key AI trends and use cases – all aimed at helping you understand the opportunities AI offers to improve the health of communities you serve.